Avanir Pharmaceuticals Overview
- Year Founded
-
1988
- Status
-
Acquired/Merged
- Employees
-
484
- Latest Deal Type
-
M&A
- Financing Rounds
-
10
- Investments
-
2
Avanir Pharmaceuticals General Information
Description
Developer of novel pharmaceutical products based in Aliso Viejo, California. The company specializes in the research, development, and commercialization of novel pharmaceutical products, which offer treatment of central nervous system disorders such as acute migraine, Alzheimer's disease, schizophrenia, dementia and behavioral dysfunction, enabling patients to recover from serious chronic diseases and stay healthy.
Contact Information
Website
www.avanir.comCorporate Office
- 30 Enterprise
- Suite 400
- Aliso Viejo, CA 92656
- United States
Corporate Office
- 30 Enterprise
- Suite 400
- Aliso Viejo, CA 92656
- United States
Avanir Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Avanir Pharmaceuticals Comparisons
Industry
Financing
Details
Avanir Pharmaceuticals Competitors (50)
One of Avanir Pharmaceuticals’s 50 competitors is Astex Pharmaceuticals, a Corporate Backed or Acquired company based in Cambridge, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Astex Pharmaceuticals | Corporate Backed or Acquired | Cambridge, United Kingdom | ||||
| Astellas Pharma | Corporation | Tokyo, Japan | ||||
| ACADIA Pharmaceuticals | Formerly VC-backed | San Diego, CA | ||||
| Curemark | Venture Capital-Backed | New York, NY | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA |
Avanir Pharmaceuticals Patents
Avanir Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022376278-A1 | Methods of treating agitation associated with alzheimer's disease | Inactive | 27-Oct-2021 | ||
| CA-3236017-A1 | Methods of treating agitation associated with alzheimer's disease | Pending | 27-Oct-2021 | ||
| EP-4422628-A1 | Methods of treating agitation associated with alzheimer's disease | Inactive | 27-Oct-2021 | ||
| US-20230131493-A1 | Methods of treating agitation associated with alzheimer's disease | Inactive | 27-Oct-2021 | ||
| WO-2023076414-A1 | Methods of treating agitation associated with alzheimer's disease | Inactive | 27-Oct-2021 | A61K31/485 |
Avanir Pharmaceuticals Signals
Avanir Pharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Avanir Pharmaceuticals Acquisitions (2)
Avanir Pharmaceuticals’s most recent deal was a Merger/Acquisition with Alamo Pharmaceuticals for . The deal was made on 23-May-2006.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Alamo Pharmaceuticals | 23-May-2006 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
| Royal Pharmaceutical | Merger/Acquisition | Diagnostic Equipment |
Avanir Pharmaceuticals FAQs
-
When was Avanir Pharmaceuticals founded?
Avanir Pharmaceuticals was founded in 1988.
-
Where is Avanir Pharmaceuticals headquartered?
Avanir Pharmaceuticals is headquartered in Aliso Viejo, CA.
-
What is the size of Avanir Pharmaceuticals?
Avanir Pharmaceuticals has 484 total employees.
-
What industry is Avanir Pharmaceuticals in?
Avanir Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Avanir Pharmaceuticals a private or public company?
Avanir Pharmaceuticals is a Private company.
-
What is the current valuation of Avanir Pharmaceuticals?
The current valuation of Avanir Pharmaceuticals is .
-
What is Avanir Pharmaceuticals’s current revenue?
The current revenue for Avanir Pharmaceuticals is .
-
How much funding has Avanir Pharmaceuticals raised over time?
Avanir Pharmaceuticals has raised $99M.
-
Who are Avanir Pharmaceuticals’s investors?
Foresite Capital, OrbiMed, ProQuest Investments, and Vivo Capital have invested in Avanir Pharmaceuticals.
-
Who are Avanir Pharmaceuticals’s competitors?
Astex Pharmaceuticals, Astellas Pharma, ACADIA Pharmaceuticals, Curemark, and Genentech are some of the 50 competitors of Avanir Pharmaceuticals.
-
When was Avanir Pharmaceuticals acquired?
Avanir Pharmaceuticals was acquired on 13-Jan-2015.
-
Who acquired Avanir Pharmaceuticals?
Avanir Pharmaceuticals was acquired by Otsuka Pharmaceutical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process